Black Rock Inc. My Md Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.22 - $0.58 $238 - $629	-1,086 Reduced 0.52%	206,078 $53,000
Q3 2023 Nov 13, 2023	SELL	$0.47 - $1.87 $1,786 - $7,107	-3,801 Reduced 1.8%	207,164 $122,000
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.26 $9,083 - $14,256	6,308 Added 3.08%	210,965 $316,000
Q1 2023 May 12, 2023	BUY	$1.1 - $2.86 $8,069 - $20,980	7,336 Added 3.72%	204,657 $352,000
Q4 2022 Feb 13, 2023	BUY	$0.92 - $96.0 $1,711 - $178,560	1,860 Added 0.95%	197,321 $226,000
Q3 2022 Nov 14, 2022	SELL	$2.22 - $82.2 $7,701 - $285,151	-3,469 Reduced 1.74%	195,461 $510,000
Q2 2022 Aug 12, 2022	SELL	$2.0 - $4.78 $9,182 - $21,944	-4,591 Reduced 2.26%	198,930 $432,000
Q1 2022 May 12, 2022	SELL	$3.34 - $6.05 $23,309 - $42,222	-6,979 Reduced 3.32%	203,521 $948,000
Q4 2021 Feb 10, 2022	BUY	$5.46 - $9.69 $348,713 - $618,871	63,867 Added 43.56%	210,500 $1.28 Million
Q3 2021 Nov 09, 2021	BUY	$4.64 - $7.94 $202,248 - $346,088	43,588 Added 42.3%	146,633 $1.06 Million
Q2 2021 Aug 11, 2021	BUY	$3.39 - $6.98 $349,322 - $719,254	103,045 New	103,045 $650,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.